G
Global Blood Therapeutics Inc
F:G5B
Global Blood Therapeutics Inc
F:G5B
Price:
68.4
EUR
-1.27%
Market Closed
Market Cap:
€4.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
G
|
Global Blood Therapeutics Inc
F:G5B
|
US |
|
Solar A/S
F:ZVR
|
DK |
|
A
|
Apotea AB (publ)
STO:APOTEA
|
SE |
|
C
|
Cornerstone Building Brands Inc
F:NCUN
|
US |
|
1
|
123fahrschule SE
F:123F
|
DE |
|
Cementir Holding NV
MIL:CEM
|
IT |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is G5B's stock price target?
Not Available
G5B doesn't have any price targets made by Wall Street professionals.
What is Global Blood Therapeutics Inc's Revenue forecast?
Projected CAGR
69%
69%
The compound annual growth rate of Global Blood Therapeutics Inc's revenue for the next 1 year is 69%.
